California Technology Assessment Forum California Technology Assessment Forum http://www.ctaf.org/ 2012-05-17T17:14:22+00:00 FeedCreator 1.7.2-ppt (info@mypapit.net) The Use of Remote Magnetic Navigation in Catheter Ablation of Atrial Arrhythmias 2012-02-08T05:15:00+00:00 2012-02-08T05:15:00+00:00 http://www.ctaf.org/content/assessment/detail/1427/ California Technology Assessment Forum It is recommended that use of remote magnetic navigation does not meet CTAF TA Criterion 1 through 5 for safety, effectiveness and improvement in net health outcomes when used for the treatment of atrial arrhythmias using radiofrequency energy catheter ablation. Transcatheter Aortic Valve Repair for Patients With Aortic Stenosis Who Cannot Undergo Surgery 2012-02-08T05:15:00+00:00 2012-02-08T05:15:00+00:00 http://www.ctaf.org/content/assessment/detail/1426/ California Technology Assessment Forum It is recommended that use of the SAPIEN transcatheter aortic valve meets CTAF TA Criterion 1 through 5 for safety, effectiveness and improvement in net health outcomes when used for the treatment of severe, symptomatic aortic stenosis in patients determined to be inoperable by a cardiac surgeon who can be treated using the transfemoral approach. Renal Stents For The Treatment of Severe Hypertension 2012-02-08T05:15:00+00:00 2012-02-08T05:15:00+00:00 http://www.ctaf.org/content/assessment/detail/1425/ California Technology Assessment Forum It is recommended that renal artery stenting for treatment of severe hypertension does not meet CTAF criteria 4 or 5 for safety, efficacy and improvement in health outcomes. Hyaluronic Acid for Treatment of Osteoarthritis of the Knee: Repeated Injections and Progression to Knee Replacement 2012-02-08T05:15:00+00:00 2012-02-08T05:15:00+00:00 http://www.ctaf.org/content/assessment/detail/1424/ California Technology Assessment Forum It is recommended that treatment of knee OA with repeated injections of intra-articular HA meets CTAF criteria 1-5 for safety, efficacy and improvement in health outcomes for osteoarthritis treatment when compared with usual care.<br><br> It is recommended that treatment of knee OA with repeated injections of intra-articular HA does not meet CTAF criteria 4 or 5 for safety, efficacy and improvement in health outcomes for progression to knee replacement or progression of disease. Bronchial Thermoplasty for the Treatment of Severe Asthma 2011-10-19T15:30:00+00:00 2011-10-19T15:30:00+00:00 http://www.ctaf.org/content/assessment/detail/1381/ California Technology Assessment Forum Metal on Metal Hip Resurfacing as an alternative to Total Hip Arthroplasty 2011-10-19T16:00:00+00:00 2011-10-19T16:00:00+00:00 http://www.ctaf.org/content/assessment/detail/1375/ California Technology Assessment Forum Metal on metal hip resurfacing using the BHR, Cormet 2000, or Conserve Plus devices does not meet CTAF criteria 3-5 for safety, efficacy and improvement in health outcomes for patients as an alternative to total hip arthroplasty. <br><br> The CTAF Panel voted unanimously to accept the recommendation. Low Dose Spiral Computerized Tomography (LDSCT) Screening for Lung Cancer 2011-10-19T16:00:00+00:00 2011-10-19T16:00:00+00:00 http://www.ctaf.org/content/assessment/detail/1374/ California Technology Assessment Forum The use of LDCT as a screening test for lung cancer in high risk individuals at specialized centers meets CTAF criteria 1-5. <br><br> The CTAF Panel voted nine in favor of the recommendation and three opposed. The motion carried. CTAF Meeting 2011-09-08T16:15:00+00:00 2011-09-08T16:15:00+00:00 http://www.ctaf.org/content/calendar/detail/1310/ California Technology Assessment Forum CTAF Meeting 2011-09-08T16:15:00+00:00 2011-09-08T16:15:00+00:00 http://www.ctaf.org/content/calendar/detail/1309/ California Technology Assessment Forum CTAF Meeting 2011-09-08T16:00:00+00:00 2011-09-08T16:00:00+00:00 http://www.ctaf.org/content/calendar/detail/1308/ California Technology Assessment Forum /files/1308_image_CTAF_Meeting_Summary_020812_v1.pdf Aqueous Shunts for the Treatment of Glaucoma 2011-06-30T03:45:00+00:00 2011-06-30T03:45:00+00:00 http://www.ctaf.org/content/assessment/detail/1304/ California Technology Assessment Forum It is recommended that use of aqueous shunts for the treatment of glaucoma not adequately controlled by medication and / or laser therapy meets CTAF TA Criterion 1 through 5 for safety, effectiveness and improvement in health outcomes. Home Telemonitoring for the Management of Heart Failure 2011-06-30T03:45:00+00:00 2011-06-30T03:45:00+00:00 http://www.ctaf.org/content/assessment/detail/1303/ California Technology Assessment Forum It is recommended that use of home telemonitoring for patients with heart failure does not meet CTAF TA Criterion 3 through 5 for safety, effectiveness and improvement in health outcomes. Cryoballoon Ablation for Atrial Fibrillation 2011-06-30T03:45:00+00:00 2011-06-30T03:45:00+00:00 http://www.ctaf.org/content/assessment/detail/1302/ California Technology Assessment Forum It is recommended that cryoablation as a treatment for atrial fibrillation does not meet meets CTAF TA criteria 4 or 5 for improvement in health outcomes. Stereotactic Body Radiation Therapy for the Treatment of Early Stage Non Small Cell Lung Cancer 2011-06-30T03:30:00+00:00 2011-06-30T03:30:00+00:00 http://www.ctaf.org/content/assessment/detail/1301/ California Technology Assessment Forum It is recommended that stereotactic body radiation therapy for the treatment of early stage non small cell lung cancer in medically inoperable patients with peripheral lesions meets CTAF criteria 2-5 for safety, effectiveness and improvement in outcomes. <br><br> It is recommended that stereotactic body radiation therapy for the treatment of early stage non small cell lung cancer in medically inoperable patients with central lesions and medically operable patients does not meet CTAF TA criteria 2-5, for safety, effectiveness, and improvement in outcomes. Radiofrequency Ablation as a Treatment of Dysplastic Barrett’s Esophagus: Low Grade Dysplasia 2011-06-30T01:45:00+00:00 2011-06-30T01:45:00+00:00 http://www.ctaf.org/content/assessment/detail/1300/ California Technology Assessment Forum RFA for the treatment of BE does not meet CTAF Criteria 4-5 for the treatment of individuals with low grade dysplasia (LGD).